Relay Therapeutics, Inc. (NASDAQ:RLAY) has 221 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 31 Mar, 2026 | 27,904,963 | 0 | 0.00% | $277,654,382.00 |
| SB INVESTMENT ADVISERS (UK) LTD | 31 Mar, 2026 | 27,904,963 | 0 | 0.00% | $236,075,987.00 |
| Commodore Capital LP | 31 Mar, 2026 | 17,000,000 | 0 | 0.00% | $143,820,000.00 |
| Commodore Capital LP | 31 Mar, 2026 | 17,000,000 | 0 | 0.00% | $169,150,000.00 |
| Casdin Capital, LLC | 31 Mar, 2026 | 14,418,574 | 1,415,000 | 10.88% | $143,464,811.00 |
| Point72 Asset Management, L.P. | 31 Mar, 2026 | 13,859,172 | -914,504 | -6.19% | $117,248,595.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 13,228,502 | -530,880 | -3.86% | $111,913,127.00 |
| Casdin Capital, LLC | 31 Mar, 2026 | 13,003,574 | 1,662,193 | 14.66% | $110,010,236.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 12,975,299 | -253,203 | -1.91% | $129,104,225.00 |
| PERCEPTIVE ADVISORS LLC | 31 Mar, 2026 | 9,751,141 | 7,847,896 | 412.34% | $97,023,853.00 |
| VANGUARD GROUP INC | 31 Mar, 2026 | 9,691,445 | 295,701 | 3.15% | $81,989,624.00 |
| Bellevue Group AG | 31 Mar, 2026 | 8,345,364 | -246 | 0.00% | $70,601,779.00 |
| Bellevue Group AG | 31 Mar, 2026 | 7,795,242 | -550,122 | -6.59% | $77,562,658.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 7,387,465 | 7,387,465 | 0.00% | $73,505,277.00 |
| State Street Corp | 31 Mar, 2026 | 6,426,111 | 1,360,121 | 26.85% | $54,364,899.00 |
| State Street Corp | 31 Mar, 2026 | 6,233,545 | -192,566 | -3.00% | $62,023,773.00 |
| Nextech Invest, Ltd. | 31 Mar, 2026 | 5,526,506 | 825,000 | 17.55% | $54,988,735.00 |
| Nextech Invest, Ltd. | 31 Mar, 2026 | 4,701,506 | 855,097 | 22.23% | $39,774,741.00 |
| TCG Crossover Management, LLC | 31 Mar, 2026 | 4,273,356 | 1,053,170 | 32.71% | $42,519,892.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 3,719,268 | 1,850,397 | 99.01% | $31,465,006.00 |